- The Lada plant in Langreo adds a fourth production line for imidacloprid.
- The plant already produces acetylsalicylic acid, butafosfan, and clotrimazole.
- The new line aims to increase pet drug production by six tonnes annually.
- The factory has necessary permits for the new veterinary production line.
New Production Line
The Lada plant in Langreo, Spain, has added a fourth production line dedicated to producing imidacloprid, an active ingredient in the anti-parasitic drug Advantix. This drug targets fleas, ticks, and sand flies on pets, helping to prevent canine leishmaniasis.
Existing Production
The facility already manufactures acetylsalicylic acid, the raw material for Aspirin, along with butafosfan, a metabolic stimulant used in veterinary practices, and clotrimazole, a treatment for fungal infections. The new production line will leverage existing equipment to increase efficiency.
Production Increase
The addition of the new line is expected to boost the plant's output by six tonnes annually. This expansion will allow the facility to meet the growing demand for veterinary anti-parasitic treatments while continuing to supply acetylsalicylic acid to other company facilities.
Regulatory Compliance
The Lada plant has obtained all necessary permits to implement the new production line. This ensures that the facility complies with regulatory standards for manufacturing veterinary pharmaceuticals.
